Impact of ABCG2 polymorphisms on the clinical outcome of TKIs therapy in Chinese advanced non-small-cell lung cancer patients
出版年份 2015 全文链接
标题
Impact of ABCG2 polymorphisms on the clinical outcome of TKIs therapy in Chinese advanced non-small-cell lung cancer patients
作者
关键词
ATP binding cassette superfamily G member 2, Polymorphism, Non-small-cell lung cancer, Overall survival, Tyrosine kinase inhibitions (TKIs) therapy
出版物
Cancer Cell International
Volume 15, Issue 1, Pages -
出版商
Springer Nature
发表日期
2015-04-18
DOI
10.1186/s12935-015-0191-3
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Trimodal therapy for stage III-N2 non-small-cell lung carcinoma: a single center retrospective analysis
- (2014) Vasileios Askoxylakis et al. BMC CANCER
- Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802): a multicentre, open-label, randomised, phase 3 study
- (2011) Caicun Zhou et al. LANCET ONCOLOGY
- Impact ofABCG2polymorphisms on the clinical outcome and toxicity of gefitinib in non-small-cell lung cancer patients
- (2011) Clara Lemos et al. PHARMACOGENOMICS
- Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2010) G. D'Addario et al. ANNALS OF ONCOLOGY
- ABCG2 polymorphisms, 34G>A and 421C>A in a Korean population: analysis and a comprehensive comparison with other populations
- (2010) K.-A. Kim et al. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
- Impact of functional ABCG2 polymorphisms on the adverse effects of gefitinib in Japanese patients with non–small-cell lung cancer
- (2009) Keiichi Akasaka et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trial
- (2009) Tetsuya Mitsudomi et al. LANCET ONCOLOGY
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
- (2008) E.A. Eisenhauer et al. EUROPEAN JOURNAL OF CANCER
- Polymorphisms inABCG2,ABCC3andCNT1genes and their possible impact on chemotherapy outcome of lung cancer patients
- (2008) Phillip J. Müller et al. INTERNATIONAL JOURNAL OF CANCER
- Pharmacogenomic and Pharmacokinetic Determinants of Erlotinib Toxicity
- (2008) Charles M. Rudin et al. JOURNAL OF CLINICAL ONCOLOGY
- Immunohistochemical expression of BCRP and ERCC1 in biopsy specimen predicts survival in advanced non-small-cell lung cancer treated with cisplatin-based chemotherapy
- (2008) Shuji Ota et al. LUNG CANCER
- Induction chemotherapy followed by concurrent chemoradiation for patients with non-operable stage III non-small-cell lung cancer
- (2008) Vega Iranzo et al. LUNG CANCER
- Contribution of the drug transporter ABCG2 (breast cancer resistance protein) to resistance against anticancer nucleosides
- (2008) C. de Wolf et al. MOLECULAR CANCER THERAPEUTICS
- Major SNP (Q141K) Variant of Human ABC Transporter ABCG2 Undergoes Lysosomal and Proteasomal Degradations
- (2008) Tomoka Furukawa et al. PHARMACEUTICAL RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search